Kevin Kotler - Feb 22, 2023 Form 3 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Lisa Peraza Attorney-in-fact for Kevin Kotler
Stock symbol
HRTX
Transactions as of
Feb 22, 2023
Transactions value $
$0
Form type
3
Date filed
3/2/2023, 03:13 PM
Previous filing
Mar 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding HRTX Common Stock 37.9K Feb 22, 2023 Direct F1
holding HRTX Common Stock 540K Feb 22, 2023 By Broadfin Holdings LLC

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HRTX Stock Option (Right to Buy) Feb 22, 2023 Common Stock 227K $2.70 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant (02/22/2023).
F2 The stock option vests and becomes exercisable in 48 equal monthly installments beginning one month after the date of grant (02/22/2023).